Medicine and Dentistry
Patient
100%
Infant
89%
Liver Disease
82%
Diseases
78%
Child
67%
Nonalcoholic Fatty Liver
64%
Microvillus
64%
Pediatrics
47%
Diagnosis
45%
Parenteral Nutrition
39%
Association
37%
Prevalence
34%
Metalloprotease Inhibitor
32%
Liver Biopsy
32%
Mast Cell
32%
Biliary Atresia
32%
Prematurity
31%
Lipid Emulsion
27%
Retina Dystrophy
25%
Photoreceptor
25%
Adult
25%
Age
24%
Biopsy
20%
Obesity
20%
Therapeutic Procedure
19%
Cell Density
19%
Complication
18%
Childbirth
16%
Restylane
16%
Marker
16%
Chronic Liver Disease
16%
Gestational Age
16%
Pediatrician
16%
Gene
16%
Metabolic Acidosis
16%
Liver
13%
Neonates
13%
Exome Sequencing
11%
Evaluation Study
10%
Young Adult
10%
Contraindication
10%
Bilirubin Glucuronide
10%
Clinician
10%
Monitoring
10%
Acidosis
10%
Syntaxin
10%
Pregnancy
9%
Symptom
9%
Pathologist
9%
Serum
9%
Congenital Malformation
8%
Fetus Development
8%
Liver Cirrhosis
8%
Kupffer Cell
8%
Liver Fibrosis
8%
Hepatocellular Carcinoma
8%
Fibrosis
8%
Childhood Obesity
8%
Etiology
7%
Eosinophil
6%
Outer Nuclear Layer
6%
Enteropathy
6%
Survival
6%
Syndrome
6%
Homozygosity
6%
Single Nucleotide Polymorphism
6%
Feeding
6%
Obstetric Delivery
5%
Maternal Diabetes Mellitus
5%
Cohort Effect
5%
Female
5%
Hispanic
5%
Adverse Event
5%
Adulthood
5%
Liver Graft
5%
Childhood
5%
Histology
5%
Medical Decision Making
5%
Enalapril Maleate
5%
Tissues
5%
Health Care Cost
5%
Enteric Feeding
5%
Motor Development
5%
Liver Function
5%
Gut
5%
Intestinal Dysmotility
5%
Development
5%
Growth
5%
Logistic Regression Analysis
5%
Total Parenteral Nutrition
5%
Patient Referral
5%
Failure to Thrive
5%
Abdominal Distension
5%
Paracetamol
5%
Diarrhea
5%
Hyperbilirubinemia
5%
Gene Mutation
5%
Staring
5%
Biochemical Marker
5%
Cognitive Development
5%
Nursing and Health Professions
Liver Disease
43%
Procedures
37%
Parenteral Nutrition
27%
Lipid Emulsion
27%
Prematurity
21%
Blindness
19%
Pediatrics
18%
Control
16%
Gestational Age
16%
Bilirubin Glucuronide
10%
Time
9%
Child
7%
Complication
5%
Evaluation Study
5%
Comorbidity
5%
Primary Medical Care
5%
Monitoring
5%
Liver Graft
5%
Combination Therapy
5%
Adverse Event
5%
Enteric Feeding
5%
Logistic Regression Analysis
5%
Biochemical Marker
5%
Hospitalization
5%
Intestinal Failure
5%
Intestine Graft
5%
Calorie
5%
Death
5%
Cholestasis
5%
Weight
5%
Hyperbilirubinemia
5%
Intestinal Dysmotility
5%